The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure
Background and Objectives: Bacterial infections represent one of the most frequent precipitating events of acute-on-chronic liver failure (ACLF) in a patient with liver cirrhosis (LC). Early diagnosis and treatment could influence the ACLF reversal rate and decrease the mortality rate in these patie...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/18/5410 |
| _version_ | 1797486618088570880 |
|---|---|
| author | Razvan Igna Irina Gîrleanu Camelia Cojocariu Laura Huiban Cristina Muzîca Ana-Maria Sîngeap Cătălin Sfarti Stefan Chiriac Oana Cristina Petrea Sebastian Zenovia Robert Nastasa Tudor Cuciureanu Remus Stafie Ermina Stratina Adrian Rotaru Carol Stanciu Mihaela Blaj Anca Trifan |
| author_facet | Razvan Igna Irina Gîrleanu Camelia Cojocariu Laura Huiban Cristina Muzîca Ana-Maria Sîngeap Cătălin Sfarti Stefan Chiriac Oana Cristina Petrea Sebastian Zenovia Robert Nastasa Tudor Cuciureanu Remus Stafie Ermina Stratina Adrian Rotaru Carol Stanciu Mihaela Blaj Anca Trifan |
| author_sort | Razvan Igna |
| collection | DOAJ |
| description | Background and Objectives: Bacterial infections represent one of the most frequent precipitating events of acute-on-chronic liver failure (ACLF) in a patient with liver cirrhosis (LC). Early diagnosis and treatment could influence the ACLF reversal rate and decrease the mortality rate in these patients. The study aimed to evaluate the role of presepsin, C-reactive protein (CRP), and procalcitonin (PCT) in the early diagnosis of bacterial infections in patients with LC and ACLF, defined according to the European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL-CLIF) criteria. Material and Methods: We performed a prospective observational study including all consecutive cirrhotic patients with ACLF admitted to our tertiary university center. The patients were follow-up until discharge. All patients were screened for infection at admission, and we included patients with community-acquired or healthcare-associated bacterial infections. Results: In this study, we included 153 patients with a median age of 60 years, of whom 65.4% were male. Infections were diagnosed in 71 patients (46.4%). The presepsin, CRP, and PCT levels were higher in patients with infections than in those without infections (<i>p</i> < 0.001, <i>p</i> = 0.023, and <i>p</i> < 0.001, respectively). The ROC analysis results demonstrated that the best cut-offs values for infections diagnosis were for presepsin 2300 pg/mL (sensitivity of 81.7%, specificity of 92.7%, AUROC 0.959, <i>p</i> < 0.001), CRP 5.3 mg/dL (sensitivity of 54.9%, specificity of 69.6%, AUROC 0.648, <i>p</i> = 0.023), and PCT 0.9 ng/mL (sensitivity of 80.3%, specificity of 86.6%, AUROC 0.909, <i>p</i> < 0.001). Presepsin (OR 3.65, 95%CI 1.394–9.588, <i>p</i> = 0.008), PCT (OR 9.79, 95%CI 6.168–25.736, <i>p</i> < 0.001), and MELD score (OR 7.37, 95%CI 1.416–18.430, <i>p</i> = 0.018) were associated with bacterial infections in patients with ACLF. Conclusion: Presepsin level ≥2300 pg/mL and PCT level ≥0.9 ng/mL may be adequate non-invasive tools for the early diagnosis of infections in cirrhotics with ACLF. |
| first_indexed | 2024-03-09T23:35:47Z |
| format | Article |
| id | doaj.art-296f16ccdcb346aeac95bb56e4afdee1 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-09T23:35:47Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-296f16ccdcb346aeac95bb56e4afdee12023-11-23T17:00:17ZengMDPI AGJournal of Clinical Medicine2077-03832022-09-011118541010.3390/jcm11185410The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver FailureRazvan Igna0Irina Gîrleanu1Camelia Cojocariu2Laura Huiban3Cristina Muzîca4Ana-Maria Sîngeap5Cătălin Sfarti6Stefan Chiriac7Oana Cristina Petrea8Sebastian Zenovia9Robert Nastasa10Tudor Cuciureanu11Remus Stafie12Ermina Stratina13Adrian Rotaru14Carol Stanciu15Mihaela Blaj16Anca Trifan17Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaDepartment of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, RomaniaBackground and Objectives: Bacterial infections represent one of the most frequent precipitating events of acute-on-chronic liver failure (ACLF) in a patient with liver cirrhosis (LC). Early diagnosis and treatment could influence the ACLF reversal rate and decrease the mortality rate in these patients. The study aimed to evaluate the role of presepsin, C-reactive protein (CRP), and procalcitonin (PCT) in the early diagnosis of bacterial infections in patients with LC and ACLF, defined according to the European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL-CLIF) criteria. Material and Methods: We performed a prospective observational study including all consecutive cirrhotic patients with ACLF admitted to our tertiary university center. The patients were follow-up until discharge. All patients were screened for infection at admission, and we included patients with community-acquired or healthcare-associated bacterial infections. Results: In this study, we included 153 patients with a median age of 60 years, of whom 65.4% were male. Infections were diagnosed in 71 patients (46.4%). The presepsin, CRP, and PCT levels were higher in patients with infections than in those without infections (<i>p</i> < 0.001, <i>p</i> = 0.023, and <i>p</i> < 0.001, respectively). The ROC analysis results demonstrated that the best cut-offs values for infections diagnosis were for presepsin 2300 pg/mL (sensitivity of 81.7%, specificity of 92.7%, AUROC 0.959, <i>p</i> < 0.001), CRP 5.3 mg/dL (sensitivity of 54.9%, specificity of 69.6%, AUROC 0.648, <i>p</i> = 0.023), and PCT 0.9 ng/mL (sensitivity of 80.3%, specificity of 86.6%, AUROC 0.909, <i>p</i> < 0.001). Presepsin (OR 3.65, 95%CI 1.394–9.588, <i>p</i> = 0.008), PCT (OR 9.79, 95%CI 6.168–25.736, <i>p</i> < 0.001), and MELD score (OR 7.37, 95%CI 1.416–18.430, <i>p</i> = 0.018) were associated with bacterial infections in patients with ACLF. Conclusion: Presepsin level ≥2300 pg/mL and PCT level ≥0.9 ng/mL may be adequate non-invasive tools for the early diagnosis of infections in cirrhotics with ACLF.https://www.mdpi.com/2077-0383/11/18/5410presepsinprocalcitoninbacterial infectionsacute-on-chronic liver failurebiomarkers |
| spellingShingle | Razvan Igna Irina Gîrleanu Camelia Cojocariu Laura Huiban Cristina Muzîca Ana-Maria Sîngeap Cătălin Sfarti Stefan Chiriac Oana Cristina Petrea Sebastian Zenovia Robert Nastasa Tudor Cuciureanu Remus Stafie Ermina Stratina Adrian Rotaru Carol Stanciu Mihaela Blaj Anca Trifan The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure Journal of Clinical Medicine presepsin procalcitonin bacterial infections acute-on-chronic liver failure biomarkers |
| title | The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure |
| title_full | The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure |
| title_fullStr | The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure |
| title_full_unstemmed | The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure |
| title_short | The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure |
| title_sort | role of presepsin and procalcitonin in early diagnosis of bacterial infections in cirrhotic patients with acute on chronic liver failure |
| topic | presepsin procalcitonin bacterial infections acute-on-chronic liver failure biomarkers |
| url | https://www.mdpi.com/2077-0383/11/18/5410 |
| work_keys_str_mv | AT razvanigna theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT irinagirleanu theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT cameliacojocariu theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT laurahuiban theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT cristinamuzica theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT anamariasingeap theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT catalinsfarti theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT stefanchiriac theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT oanacristinapetrea theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT sebastianzenovia theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT robertnastasa theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT tudorcuciureanu theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT remusstafie theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT erminastratina theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT adrianrotaru theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT carolstanciu theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT mihaelablaj theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT ancatrifan theroleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT razvanigna roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT irinagirleanu roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT cameliacojocariu roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT laurahuiban roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT cristinamuzica roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT anamariasingeap roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT catalinsfarti roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT stefanchiriac roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT oanacristinapetrea roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT sebastianzenovia roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT robertnastasa roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT tudorcuciureanu roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT remusstafie roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT erminastratina roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT adrianrotaru roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT carolstanciu roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT mihaelablaj roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure AT ancatrifan roleofpresepsinandprocalcitonininearlydiagnosisofbacterialinfectionsincirrhoticpatientswithacuteonchronicliverfailure |